Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy

Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy

Abstract Aims High mobility group box‐1 (HMGB1) is one of the damage‐associated molecular patterns produced by stress and induces inflammatory responses mediated by receptors of advanced glycation end‐products (RAGE) on the cell surface. Meanwhile, soluble RAGE (sRAGE) exhibits an anti‐inflammatory...

Full description

Bibliographic Details
Main Authors: Hiromi Abe, Mami Okada‐Tsuchioka, Naoto Kajitani, Wataru Omori, Kei Itagaki, Chiyo Shibasaki, Shuken Boku, Tetsuaki Matsuhisa, Minoru Takebayashi
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Neuropsychopharmacology Reports
Subjects:
depression
electroconvulsive therapy (ECT)
high mobility group box‐1 protein (HMGB1)
inflammation
the receptor of advanced glycation end‐products (RAGE)
Online Access:https://doi.org/10.1002/npr2.12358

Internet

https://doi.org/10.1002/npr2.12358

Similar Items